CompanyNasdaqPetach Tikva, L3
PolyPid Ltd
PolyPid develops long-acting, controlled-release drugs for surgical care and metabolic diseases.
SCHEDULE 13G/ANov 13Latest SEC filing
Form DJun 23$27M sold
November 2026
October 2026
August 2026
July 2026
PolyPid develops long-acting, controlled-release drugs for surgical care and metabolic diseases.
November 2026
October 2026
August 2026
July 2026